FKBPL Recombinant Human produced in E.Coli is a single, non-glycosylated polypeptide chain containing 357 amino acids (1-349 a.a.) and having a molecular mass of 39.2 kDa. The FKBPL is fused to an 8 amino acid His-Tag at C-terminus and purified by proprietary chromatographic techniques.
METPPVNTIG EKDTSQPQQE WEKNLRENLD SVIQIRQQPR DPPTETLELE VSPDPASQIL EHTQGAEKLV AELEGDSHKS HGSTSQMPEA LQASDLWYCP DGSFVKKIVI RGHGLDKPKL GSCCRVLALG FPFGSGPPEG WTELTMGVGP WREETWGELI EKCLESMCQG EEAELQLPGH SGPPVRLTLA SFTQGRDSWE LETSEKEALA REERARGTEL FRAGNPEGAA RCYGRALRLL LTLPPPGPPE RTVLHANLAA CQLLLGQPQL AAQSCDRVLE REPGHLKALY RRGVAQAALG NLEKATADLK KVLAIDPKNR AAQEELGKVV IQGKNQDAGL AQGLRKMFGL EHHHHHH.
FK506 Binding Proteins (FKBPs) are a family of proteins that have garnered significant interest due to their role in various cellular processes and their interaction with immunosuppressive drugs such as FK506 (tacrolimus) and rapamycin . These proteins are known for their peptidyl-prolyl cis-trans isomerase (PPIase) activity, which aids in protein folding and function .
FKBPs are characterized by their ability to bind to FK506 and rapamycin, forming complexes that inhibit the phosphatase activity of calcineurin . This inhibition is crucial for the immunosuppressive effects of these drugs, particularly in preventing organ rejection post-transplantation . The FKBP family includes several members, each with distinct functions and tissue distributions .
One of the most studied members of this family is FKBP12. It binds to FK506 and rapamycin, inhibiting calcineurin and thus blocking T-cell activation . FKBP12 is also involved in the regulation of calcium channels, such as the ryanodine receptor, which plays a critical role in calcium signaling pathways .
The unique properties of FKBPs have made them valuable tools in biological research. For instance, FKBP12 can be used in chemically induced dimerization applications to manipulate protein localization and signaling pathways . Additionally, the immunosuppressive properties of FKBP-binding drugs have been harnessed in clinical settings to prevent organ rejection and treat autoimmune diseases .